Patent details
EP3692983 Title: ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF
Basic Information
- Publication number:
- EP3692983
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP192131480
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF
- French Title of Invention:
- FORMULATIONS ORALES D'ANALOGUES DE CYTIDINE ET LEURS PROCÉDÉS D'UTILISATION
- German Title of Invention:
- ORALE FORMULIERUNGEN VON CYTIDINANALOGA UND VERFAHREN ZUR VERWENDUNG DAVON
- SPC Number:
Dates
- Filing date:
- 14/05/2009
- Grant date:
- 11/08/2021
- EP Publication Date:
- 12/08/2020
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 11/08/2021
- EP B1 Publication Date:
- 11/08/2021
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 14/05/2029
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 01/03/2024
- Name:
- Celgene Corporation
- Address:
- Route 206 & Province Line Road, Princeton, NJ 08543, United States (US)
History of Owners
- From:
- 04/08/2021
- To:
- 01/03/2024
- Name:
- Celgene Corporation
- Address:
- 86 Morris Avenue, Summit, NJ 07901, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 19/08/2021
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- ETTER, Jeffrey B
- Address:
- United States (US)
2
- Name:
- BACKSTROM, Jay T
- Address:
- United States (US)
3
- Name:
- LAI, Mei
- Address:
- United States (US)
Priority
1
- Priority Number:
- 5360908 P
- Priority Date:
- 15/05/2008
- Priority Country:
- United States (US)
2
- Priority Number:
- 20114508 P
- Priority Date:
- 05/12/2008
- Priority Country:
- United States (US)
3
- Priority Number:
- 15787509 P
- Priority Date:
- 05/03/2009
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61P 1/00; A61K 9/20; A61K 9/28; A61K 31/7068; A61P 1/18; A61P 15/08; A61P 35/00; A61P 35/02; A61P 43/00; A61K 47/26;
Publication
Bulletin
- Bulletin Heading:
- VB2
- Bulletin edition number:
- 2026/02
- Publication date:
- 05/02/2026
- Description:
- Section J : Applications for patents or supplementary protection certificates having been restored (art. 40 of the law) Patents or supplementary protection certificates having been restored (art. 70 of the law)
European Patent Bulletin
1
- Issue number:
- 202132
- Publication date:
- 11/08/2021
- Description:
- Grant (B1)
2
- Issue number:
- 202223
- Publication date:
- 08/06/2022
- Description:
- Opposition procedure started
3
- Issue number:
- 202542
- Publication date:
- 15/10/2025
- Description:
- Opposition rejected; Patent maintained as granted
4
- Issue number:
- 202414
- Publication date:
- 03/04/2024
- Description:
- Change of owner's name or address
Annual Fees
- Annual Fee Due Date:
- 01/06/2026
- Annual Fee Number:
- 18
- Annual Fee Amount:
- 262 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 29/04/2025
- Last Annual Fee Paid Number:
- 17
- Last Annual Fee Paid Amount:
- 246 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 19/08/2021 | Power Of Attorney | 1 |
| 19/08/2021 | Outgoing Correspondence | 1 |